Tetanus toxin is a highly potent neurotoxin produced by the anaerobic bacterium Clostridium tetani. The toxin blocks release of inhibitory transmitter substances from central synapses (21) after a process that involves binding to ganglioside receptors at the nerve termini, receptor-mediated endocytosis, intra-axonal transport, and transsynaptic transfer (13, 25) .
The structural gene for the toxin is located on a 75-kilobase (kb) plasmid (8, 11, 16) and has been sequenced recently (8, 9) . The toxin (Mr 150,700) is synthesized as a single-chain polypeptide. Upon release from the bacterium, it is processed by endogenous proteases into two subunits, designated A and BC, which are held together by a single disulfide bond (4, 8) . Proteolytic cleavage is paralleled by an increase in toxicity (3, 35) , and the A-fragment is translocated into the cytoplasm to block transmitter release (2) .
Efficient resistance to tetanus is induced by vaccination with formaldehyde-treated toxin or toxin subfragments (10, 15, 34) . In this study we searched for an in vitro system that allows the characterization of toxin-neutralizing antibodies. For this purpose, we first compared different cell-free systems for their capacity to produce nontoxic peptides from cloned toxin-specific DNA. We show that a transcriptiontranslation system established from a nontoxigenic strain of C. tetani was superior to other systems in furnishing fullsized peptides. Second, we mapped epitopes for monoclonal antibodies originally raised against tetanus toxin or toxoid with recombinant polypeptides. Third, two antibodies, binding to different epitopes within the C-terminal part of the BC-fragment, blocked the toxin-specific effects on the release of norepinephrine from rat brain homogenates in vitro. A third antibody which did not show the toxin-neutralizing effect was inhibited by a synthetic peptide carrying a human T-cell epitope.
MATERIALS AND METHODS Bacteria and plasmids. C. tetani EK11, a nontoxigenic variant of E88 (strain Massachusetts), was kindly provided by Dr. Engelhardt (Behringwerke, Marburg, Federal Repub-* Corresponding author. lic of Germany [FRG] ). Escherichia coli JM101 (23) and HB101 (6) were used for purification of pUC12 and pUC13, pSP64 and pSP65 (22) , or pGEM1 and pGEM2 plasmid vectors (Promega Biotech, Madison, Wis.). The pEx3la, pEx3lb, and pEx31c vectors (32) Cloning of DNA. Cloning of defined tetanus toxin-specific DNA fragments (Table 1) was performed under L2B1 containment following standard protocols (18) . For nucleotide numbers defining the positions within the tetanus toxin gene, see Eisel et al. (8) . The vectors pEJ5 and pEJ97, described previously (8) , contain the toxin promoter region within 548 and 322 5' noncoding nucleotides, respectively, placed upstream from the tetS and tet97 sequences listed in Table 1 .
In vitro synthesis of capped mRNA. The details of in vitro transcription have been described previously (19) . The characteristics of the transcripts and of the corresponding peptides are summarized in Characterization of the expression products. Samples of the assay mixes were analyzed under reducing conditions by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) on 13% polyacrylamide gels. Immunoprecipitations with protein A-Sepharose were performed in RIPA buffer as described previously (26) . For Western immunoblotting analyses, the method of Blake et al. (5) was used. Enzyme linked immunosorbent assay (ELISA) reactions were performed with the immunoglobulin G (IgG)-horseradish peroxidase method (33) .
Immunization of rabbits with toxin-specific fusion proteins.
Fusion proteins containing an N-terminal part of the MS2 polymerase fused in frame to the Tet5, Tet7, or Teti5 regions of the toxin were induced and purified as described before (8, 32 preloaded suspension (2% wt/vol) was mixed with 100 ,ul of a solution of tetanus toxin (200 ng/ml in KRH containing 0.1% bovine serum albumin) which had been preincubated for 30 min at room temperature with the individual antiserum or preimmune serum. After 2 h at 37°C, the samples were transferred to Millipore GF-C glass fiber filters and washed with KRH buffer for 15 min. For a 2-min pulse, the potassium ion concentration was increased to 31 mM, while the sodium ion concentration was simultaneously reduced to 106 mM. This treatment generally released about 40% of the total radiolabel from control samples. The capacity of individual antisera to abolish the inhibitory effects of tetanus toxin on release was determined by measuring the levels of extracellular and total radiolabeled norepinephrine. Each antiserum was tested in three independent experiments, yielding essentially identical results. Toxin neutralization studies involving monoclonal antibodies were initially performed with unpurified ascites fluids. When toxin neutralization was observed, tests were repeated with purified IgG at concentrations corresponding to the dilutions in Table 2 .
RESULTS
In vitro synthesis of tetanus toxin-specific fragments from in vitro-synthesized mRNA. Our first approach to obtain defined toxin-specific peptides was based on the in vitro synthesis of mRNA and its subsequent translation in appropriate translation systems. Five different constructs containing different fragments of the toxin gene ( Fig. 1) were prepared in pSP64 or pGEM vectors as explained in Table 1 .
By using SP6 RNA polymerase and DNA templates that were linearized downstream from the toxin-specific sequences, mRNA of the expected size was obtained in microgram yields (data not shown). For subsequent translation assays in reticulocyte lysate, the mRNA was capped by adding the capping analog m7G5'ppp5'G in a 10-fold excess over GTP. In the wheat germ system, capping did not improve the translation efficiency, as also documented by others (29) . (Table 1) were obtained, smaller peptides of identical size were formed from tet97 and tetS mRNAs, indicating that these smaller products could arise from premature termination of translation. The formation of the second-largest product obtained from pGEMtet9 could result from ribosomal slippage and initiation at a second AUG codon 61 nucleotides downstream from initiation codon 2427. In general, the reticulocyte lysate system yielded larger amounts of peptides than were obtained in the wheat germ system. It should be noted, however, that both eucaryotic systems were less efficient in translating internal or C-terminal sequences of the toxin molecule.
Cell-free protein synthesis in E. coli or C. tetani lysates. The constructs pEJ5 and pEJ97 contained 5' noncoding sequences harboring the toxin promoter shown to be functional in E. coli (8) . Figure 3 shows that polypeptides of the expected size, 64 and 47 kilodaltons (kDa), were obtained. The replacement of the toxin promoter by strong E. coli promoters (such as lac or tac), as well as the replacement of the clostridial Shine-Dalgarno sequence by a synthetic sequence corresponding to the ompA gene, did not improve yields. In addition, neither modification of ionic conditions nor alteration of the spermidine or ATP concentration led to full-sized products (data not shown). In some instances, as shown for pEJ6 (Fig. 3, lane 6) , the majority of radiolabel was apparently incorporated into P-lactamase (indicated by the arrowheads). synthesis was obtained with 10 pug of exogenous total RNA from C. tetani (Fig. 4A) . It should be noted that a plateau value was not reached even at the highest RNA concentration tested (666 pug/ml). Stimulation by exogenous DNA was less efficient than stimulation by RNA. In combined transcription-translation assays, the best results were obtained with 2 to 5 ,ug of supercoiled DNA, yielding a 3.5-fold stimulation of protein synthesis.
The clostridial system was superior to the previous systems since it yielded predominantly full-sized peptides, irrespective of whether the toxin-specific sequences were derived from the N-or C-terminal part of the molecule (Fig.  4B) . With none of the other systems could the 23,100-Da peptide, representing Tet4 (Fig. 1) , be obtained in adequate amounts. This peptide was expressed at high levels under control of the toxin promoter (Fig. 4B, lane d) . The clostridial system, however, was not very efficient when expression was driven by the lac promoter. From pEJ6, for example, the largest detectable peptide (32,000 Da) was considerably smaller than the expected 41,580-Da species. In vitro studies involving RNA polymerase purified from C. tetani indicated that this polymerase transcribed genes under control of the lac or tac promoter, albeit at a reduced efficiency (U. Eisel and H. Niemann, unpublished).
Mapping of antigenic determinants. In a first attempt to apply peptides synthesized in the clostridial system in the characterization of 22 different monoclonal antibodies raised against tetanus toxin or toxoid (1), we performed immunoprecipitation reactions (Table 2 ). Figure 4C shows an example of such an experiment. Antibody 993D5 precipitated the Tet97 and Tet5 peptides equally well (lanes a and c), while antibody 161D6 or 162D2 recognized Tet97 exclusively, indicating that the corresponding epitope was located within the additional C-terminal sequences present in Tet97. Since these latter two antibodies were specific for the BC-fragment (Table 2) , their epitopes had to reside within region II in Fig.   1 .
To our surprise, however, only eight monoclonal antibodies (Table 2 ) could be applied successfully in immunoprecipitations of in vitro-translated peptides. The amounts of recombinant peptides obtained by in vitro translations were not sufficient to be analyzed by ELISA or Westem blotting. Therefore, we extended our studies to fusion proteins synthesized in E. coli (Fig. 5) Fig. 1 (5).
homogenate. The toxin-neutralizing properties of the monoclonal antibodies listed in Table 2 were tested together with those of polyclonal sera raised against fusion proteins in an in vitro assay based on the inhibitory effects of tetanus toxin on the release of [3H]norepinephrine from brain homogenate prelabeled with the hormone (12) . The results are summarized in Table 2 contrast, antibodies that recognized domains within the A-fragment, such as 993D5 and anti-tet5, were less efficient in neutralizing the toxin in this in vitro assay.
DISCUSSION
We used recombinant tetanus toxin-specific peptides to characterize the epitopes of monoclonal antibodies whose toxin-neutralizing activity was determined in an in vitro assay. Four different cell-free systems were compared for their efficiency in producing subfragments of the toxin molecule in vitro from cloned DNA. This study was carried out because previous experiments had indicated that clostridial DNA with a G+C content of merely 27% was expressed at low levels in E. coli (8) . Our studies showed that clostridial DNA yielded preferentially full-sized peptides in a homologous cell-free system developed from a nontoxigenic strain of C. tetani. Optimization studies revealed a similar dependency of this system on Mg2+ (13 to 15 mM) and K+ (80 mM) as described for systems from E. coli (27) , Bacillus subtilis (17, 20, 36) , and Clostridium pasteurianum (30, 31 In reticulocyte lysate and wheat germ extract systems, the translation efficiency of presynthesized toxin-specific mRNA was quite low in comparison to that of standard globin or coronaviral mRNA (19) . In both systems, premature termination of translation was a major reason for the reduced yields. The combined transcription-translation system forE. coli did not prove satisfactory with clostridial DNA. Even though ribosomes from gram-negative bacteria have been reported to be less restricted with respect to the nature of the mRNA than ribosomes from gram-positive organisms (31), exogenously added total clostridial RNA was translated quite inefficiently in the E. coli system (not shown). In addition, peptides encoded by entirely toxin-specific DNA were again poorly synthesized in vivo, while MS2 fusion proteins were made in normal amounts, as shown in Fig. 5 . These findings suggest that in this system, initiation of translation could play the crucial role.
Using such recombinant peptides, we coarsely mapped the epitopes of eight monoclonal antibodies. Of a total of 22 different antisera, all of which were shown previously to bind to tetanus toxin (1), only 8 reacted with toxin fragments produced either in vitro or in vivo, as determined by immunoprecipitation, ELISA, or Western blotting. These eight monoclonal antibodies recognized six different epitopes.
None of the eight antibodies alone was capable of neutralizing 10 50% lethal doses when coinjected into mice; each only prolonged the time to death. Similar observations have been reported previously (24, 34) . However, such in vivo experiments are costly in terms of test animals and monoclonal antisera. Therefore, to assess the toxin-neutralizing activity of monoclonal antibodies, we used an in vitro system in which the essential steps of the toxification process, namely, binding and internalization of the toxin, are maintained. Our data demonstrate that sera directed against the A-subunit of tetanus toxin, such as polyclonal rabbit VOL. 57, 1989 anti-Tet5 or the monoclonal antibody 993D5, which could be used in immunoprecipitations and thus presumably also bind to the toxin in solution, barely neutralized the toxin. Similar properties of monoclonal antibodies against the A-fragment have been reported previously (34) . Three epitopes were mapped with the help of monoclonal antibodies in the B-fragment. This domain of the toxin has been suggested to play an important role in the interaction of the toxin with a putative proteinaceous receptor (25) and could be involved in the translocation of the A-subunit into the cytosole (reviewed in reference 13). One of the antibodies (104A1) caused marked neutralization of the toxin by binding to region IV, while antibodies 162D2 and 161D6, both recognizing region II of the toxin and both useful in immunoprecipitations, only reduced the toxin effects to about 20% of the value without antibody. Unfortunately, no conclusions concerning binding of antibodies to epitopes III and V can be drawn, since the corresponding antibodies (161A1 for region III, 164B4 and 165B2 for region V) did not bind to radiolabeled tetanus toxin in solution (data not shown). In competitive ELISA reactions, binding of the latter two antibodies to region V could be specifically inhibited by the synthetic peptide NH2-F(947)NNFTVSFWLRVPKVSASHLE(967), carrying a human T-cell epitope (7) . Apparently region V becomes exposed at the periphery of the molecule only after treatment with detergent or, in the host, after proteolytic processing by antigen-presenting cells. Our finding suggests that B cells and T cells can principally recognize the same epitope. We cannot exclude, however, that a peptide of 21 amino acids exhibits more than the one epitope and that the murine B-cell and the human T-cell clones therefore recognize two different sites. Recently, a pentapeptide sequence from human cytomegalovirus was demonstrated to be sufficient for major histocompatibility complex-restricted T-cell stimulation (28) . Systematic modifications of the peptide from either end will now allow the precise characterization of the T-and B-cell epitope(s). In agreement with published observations (10, 15, 34) , antibodies binding to fragment-C showed the most pronounced toxin-neutralizing activities. This is not surprising, since fragment-C has been shown to be nearly as effective as the holotoxin with respect to binding to thyroid or neural membranes or to certain gangliosides. Recent 
